Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/21/2025

Treatment of Influenza in Children

Weight-Based Dosing Algorithm

  • The American Academy of Pediatrics recommends oseltamivir administration at a weight-based dose: 30 mg twice daily for children ≤15 kg, 45 mg twice daily for children >15-23 kg, given orally for 5 days, ideally initiated within 48 hours of symptom onset 1, 2, 3
  • For children ≤15 kg, the recommended dose is 30 mg (5 mL of oral suspension) twice daily for 5 days 1, 2, 3
  • For children >15-23 kg, the recommended dose is 45 mg (7.5 mL of oral suspension) twice daily for 5 days 1, 2, 3
  • For children >23-40 kg, the recommended dose is 60 mg (10 mL of oral suspension) twice daily for 5 days 1, 2, 3

Formulation and Administration

  • Oseltamivir is available as an oral suspension at 6 mg/mL concentration, which is the preferred formulation for this age group 1, 2, 3
  • If the commercially manufactured suspension is unavailable, pharmacies can compound a suspension by mixing capsule contents with simple syrup or Ora-Sweet SF to achieve 6 mg/mL concentration 1, 3
  • Administer oseltamivir with food to reduce gastrointestinal side effects, which occur in approximately 10-15% of patients 2, 3

Timing of Treatment Initiation

  • Treatment must be started within 48 hours of symptom onset for maximum benefit 1, 3
  • Even when initiated after 48 hours, treatment should still be considered in children with moderate-to-severe or progressive disease 1

Indications for Treatment

  • Treat all 1-year-olds with confirmed or suspected influenza who present within 48 hours of symptom onset 1, 4, 5
  • Children under 2 years are at increased risk for hospitalization and complications from influenza 1

Safety Profile

  • Oseltamivir is FDA-approved for treatment in children as young as 2 weeks of age 1, 3
  • In infants and young children, the safety profile is similar to older children 1, 3

Critical Pitfalls to Avoid

  • Do not round up to the next weight category – a child weighing exactly 15 kg should receive 30 mg, not 45 mg 2
  • Do not delay treatment waiting for laboratory confirmation in high-risk patients (children <2 years) during influenza season 1, 3
  • Ensure accurate volume measurement using a calibrated oral dosing device, not household spoons 2
  • Complete the full 5-day course even if symptoms improve earlier 1, 3

Special Considerations

  • For children with renal impairment (creatinine clearance 10-30 mL/min), reduce the dose to 30 mg once daily instead of twice daily 3
  • Oseltamivir can be used safely in children with common comorbidities including asthma, chronic pulmonary disease, cardiovascular disease, and diabetes – these are not contraindications 3